Press Releases 2013
 
Press Releases 2012
 
Press Releases 2011
 
Press Releases 2010
 
Press Releases 2009
 
Press Releases 2008
 
Press Releases 2007
 
Press Releases 2006
 
Press Releases 2005
 
Press Releases 2004
 
Press Releases 2003
 
 
11.07.11
Ironwood Pharmaceuticals Provides Third Quarter 2011 Investor Update

11.02.11
Ironwood Pharmaceuticals to Present at Credit Suisse 2011 Healthcare Conference

10.31.11
Ironwood Pharmaceuticals to Host Third Quarter 2011 Investor Update Call

10.27.11
Ironwood and Forest to Present Linaclotide Results from Phase 2b and Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation or Chronic Constipation
- Data to be presented at ACG 2011 Annual Scientific Meeting

10.24.11
Ironwood and Forest Announce Linaclotide New Drug Application for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation Accepted for FDA Review

09.29.11
Ironwood Announces Linaclotide European Regulatory Submission for the Treatment of Irritable Bowel Syndrome with Constipation

09.21.11
Ironwood Pharmaceuticals to Present at Jefferies 2011 Global Healthcare Conference

09.06.11
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference

08.11.11
Ironwood Pharmaceuticals Provides Second Quarter 2011 Investor Update

08.10.11
Ironwood Pharmaceuticals to Present at Wedbush Securities 2011 Life Sciences Management Access Conference

08.09.11
Ironwood and Forest Announce Submission of New Drug Application for Linaclotide for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Constipation

08.08.11
Ironwood Pharmaceuticals to Host Second Quarter 2011 Investor Update Call

07.27.11
Ironwood Pharmaceuticals and Depomed Announce Collaboration, Research and License Agreement
- Enables Ironwood Early Stage Development Program

05.31.11
Ironwood Pharmaceuticals Announces Upcoming Presentations at Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference

05.12.11
Ironwood Pharmaceuticals Provides First Quarter 2011 Investor Update

05.05.11
Ironwood Pharmaceuticals to Host First Quarter 2011 Investor Update Call

05.04.11
Ironwood and Forest to Present Linaclotide Results from Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation
- Data to be presented at Digestive Disease Week 2011

05.04.11
Ironwood Pharmaceuticals Announces Upcoming Presentation at Bank of America Merrill Lynch 2011 Health Care Conference

03.03.11
Ironwood Pharmaceuticals Provides Fourth Quarter 2010 Investor Update

03.03.11
Ironwood Pharmaceuticals Announces Upcoming Presentation at Cowen and Company Annual Health Care Conference

02.28.11
Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call

01.18.11
Ironwood and Protagonist Establish Collaboration for Peptide Drug Discovery and Development

01.06.11
Ironwood Pharmaceuticals Announces Upcoming Presentation at J.P. Morgan Healthcare Conference

 

Lisa Buffington
VP, Corporate Communications
617.374.5103
 
         
Copyright © 2013, Ironwood Pharmaceuticals, Inc.All Rights Reserved|Privacy Policy|Terms of Service|Site Design